Authors:
Stein, H
Marafioti, T
Foss, HD
Laumen, H
Hummel, M
Anagnostopoulos, I
Wirth, T
Demel, G
Falini, B
Citation: H. Stein et al., Down-regulation of BOB.1/OBF.1 and Oct2 in classical Hodgkin disease but not in lymphocyte predominant Hodgkin disease correlates with immunoglobulintranscription, BLOOD, 97(2), 2001, pp. 496-501
Authors:
Marafioti, T
Hummel, M
Foss, HD
Laumen, H
Korbjuhn, P
Anagnostopoulos, I
Lammert, H
Demel, G
Theil, J
Wirth, T
Stein, H
Citation: T. Marafioti et al., Hodgkin and Reed-Sternberg cells represent an expansion of a single clone originating from a germinal center B-cell with functional immunoglobulin gene rearrangements but defective immunoglobulin transcription, BLOOD, 95(4), 2000, pp. 1443-1450
Citation: B. Heine et al., Hodgkin and Reed-Sternberg cells of classical Hodgkin's disease overexpress the telomerase RNA template (hTR), J PATHOLOGY, 188(2), 1999, pp. 139-145
Authors:
Mann, B
Gratchev, A
Bohm, C
Hanski, ML
Foss, HD
Demel, G
Trojanek, B
Schmidt-Wolf, I
Stein, H
Riecken, EO
Buhr, HJ
Hanski, C
Citation: B. Mann et al., FasL is more frequently expressed in liver metastases of colorectal cancerthan in matched primary carcinomas, BR J CANC, 79(7-8), 1999, pp. 1262-1269
Authors:
Foss, HD
Reusch, R
Demel, G
Lenz, G
Anagnostopoulos, I
Hummel, M
Stein, H
Citation: Hd. Foss et al., Frequent expression of the B-cell-specific activator protein in Reed-Sternberg cells of classical Hodgkin's disease provides further evidence for itsB-cell origin, BLOOD, 94(9), 1999, pp. 3108-3113
Authors:
Emmerich, F
Meiser, M
Hummel, M
Demel, G
Foss, HD
Jundt, F
Mathas, S
Krappmann, D
Scheidereit, C
Stein, H
Dorken, B
Citation: F. Emmerich et al., Overexpression of I kappa B alpha without inhibition of NF-kappa B activity and mutations in the I kappa B alpha gene in Reed-Sternberg cells, BLOOD, 94(9), 1999, pp. 3129-3134
Authors:
Durkop, H
Foss, HD
Demel, G
Klotzbach, H
Hehn, C
Stein, H
Citation: H. Durkop et al., Tumor necrosis factor receptor-associated factor 1 is overexpressed in Reed-Sternberg cells of Hodgkin's disease and Epstein-Barr virus-transformed lymphoid cells, BLOOD, 93(2), 1999, pp. 617-623